Press Releases

Sixth-Annual Patient Choice Awards

August

02

MMIT Announces Sixth-Annual Specialty Pharmacy Patient Choice Awards Finalists

Finalists across four categories represent leading specialty pharmacies with a dedication to top-notch customer satisfaction.

Aug. 3, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—has announced the finalists of the sixth-annual Specialty Pharmacy Patient Choice Awards—based on patient satisfaction survey results from the previous year.

Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail. The finalists and winners are calculated based on the highest average Net Promoter Score (NPS) from the Zitter Insights Specialty Pharmacy Patient Satisfaction Survey, which provides clients with data they can trust to help them improve patient satisfaction and increase scripts. NPS is a well-established research method that measures customer satisfaction.

“We’re thrilled to once again recognize those who are leading the pack in the specialty pharmacy industry,” said MMIT CEO Mike Gallup. “2020 was a challenging year, but these organizations demonstrated an unwavering commitment to their patients. Congratulations to all of the finalists.”

The finalists include:

Hospital & Health System Specialty Pharmacy:

Independent Specialty Pharmacy:

Payer/PBM Specialty Pharmacy:

Retail Specialty Pharmacy:

The winners will be announced at an awards ceremony hosted by MMIT at the Asembia Specialty Pharmacy Summit, held Oct. 26-29 in Las Vegas.

Featured
Emerging-Treatments-Offer-New-Hope-Alcohol-Use-Disorder

Emerging Treatments Offer New Hope for Alcohol Use Disorder

Key-Takeaways-Rare-Disease-Commercialization

Competitive ATTR Dynamics: Key Takeaways for Rare-Disease Commercialization

Alternative-Funding-Programs

Alternative Funding Programs: Short-Term Savings, Long-Term Consequences

Topics
Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch